Area of research
Infectious Diseases · Virology
Research interest
Research interests include HIV/AIDS Research and Interventions, HIV/AIDS drug development and treatment, HIV Research and Treatment, and HIV-related health complications and treatments.
Infants at highest risk of herpes simplex virus disease who should start immediate empiric aciclovir.
Value of targeted testing for cytomegalovirus in preterm infants: 7 years' experience at a tertiary London hospital.
Joint British Association for Sexual Health and HIV and Royal College of Obstetricians and Gynaecologists national UK guideline for the management of herpes simplex virus (HSV) in pregnancy and the neonate (2024 update).
Polymicrogyria in infants with symptomatic congenital cytomegalovirus at birth is associated with epilepsy: A retrospective, descriptive cohort study.
Congenital CMV infection and central nervous system involvement: mechanisms, treatment, and long-term outcomes.
How is mum? Think herpes in unwell mother and baby pairs: a multicentre case series.
Consensus recommendation for prenatal, neonatal and postnatal management of congenital cytomegalovirus infection from the European congenital infection initiative (ECCI).
Resurgence of congenital syphilis: new strategies against an old foe.
Epidemiology and Management of Pediatric Group A Streptococcal Pneumonia With Parapneumonic Effusion: An Observational Study.
Guidelines and practice of breastfeeding in women living with HIV-Results from the European INSURE survey.
Preventing perinatal HIV acquisition; current gaps and future perspectives.
Infant feeding: emerging concepts to prevent HIV transmission.
What are the neurodevelopmental outcomes of children with asymptomatic congenital cytomegalovirus infection at birth? A systematic literature review.
British Association of Sexual Health and HIV (BASHH) UK guidelines for the management of syphilis in pregnancy and children 2024.
Evolution of CD4 T-Cell Count With Age in a Cohort of Young People Growing Up With Perinatally Acquired Human Immunodeficiency Virus.
Corrigendum to "Consensus recommendation for prenatal, neonatal and postnatal management of congenital cytomegalovirus infection from the European congenital infection initiative (ECCI)" [The Lancet Regional Health - Europe 40 (2024) 100892].
Congenital CMV Monthly International Virtual Clinics: A cCMVnet European Initiative.
Hospitalisation rates for youth living with perinatally acquired HIV in England.
Population Pharmacokinetics of Dolutegravir in African Children: Results From the CHAPAS-4 Trial.
Immunoglobulin, glucocorticoid, or combination therapy for multisystem inflammatory syndrome in children: a propensity-weighted cohort study.
Managing challenges in congenital CMV: current thinking.
Neuropsychiatric manifestations and sleep disturbances with dolutegravir-based antiretroviral therapy versus standard of care in children and adolescents: a secondary analysis of the ODYSSEY trial.
Infant postnatal prophylaxis following maternal viraemia during breastfeeding.
Congenital Infections: Priorities and Possibilities for Resource-limited Settings.
Discrepancies in Management of Congenital Cytomegalovirus in Preterm Infants: An International Survey.
Once-daily dolutegravir-based antiretroviral therapy in infants and children living with HIV from age 4 weeks: results from the below 14 kg cohort in the randomised ODYSSEY trial.
Dolutegravir twice-daily dosing in children with HIV-associated tuberculosis: a pharmacokinetic and safety study within the open-label, multicentre, randomised, non-inferiority ODYSSEY trial.
What babies need: accelerating access to current and novel antiretroviral drugs in neonates through pharmacokinetic studies.
Delays in diagnosis and treatment initiation for congenital cytomegalovirus infection - Why we need universal screening.